LaskaEMMeisnerMJ. Testing whether an identified treatment is best. Biometrics1989;45: 1139–1151.
2.
LeungHMO'NeillT. Statistical assessment of combination drugs — A regulatory view. Proceedings of the Biopharmaceutical Section of the American Statistical Association. 33–36.
3.
SnapinnSM. Evaluating the efficacy of A combination therapy. Statistics in Medicine.1987;6: 657–665.
4.
NgTHHungHMHChiGYH. A new statistical method for testing a combination therapy's superiority to both of its components. Proceedings of the Biopharmaceutical Section of the American Statistical Association, 1989.
5.
BoxGEPDraperNR. Empirical model-building and response surface. New York: John Wiley & Sons; 1987.
6.
KuriICornellJA. Response surfaces designs and analyses. New York: Marcel Dekker; 1987.
7.
CarterWHJr.Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy. Cancer Treatment Reports. 1985;(10):1049–1053.
8.
HungHMJNgTHChiGYHLipickyRJ. Testing for the existence of a dose combination beating its components. Proceedings of the Biopharmaceutical Section of the American Statistical Association. 1989.
9.
HolmS. A Simple sequentially rejective multiple test procedure. Scandinavia Journal of Statistics.1979;6: 65–70.